Ferris Capital’s iShares Biotechnology ETF IBB Stock Holding History

Ferris Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$3.19M	Buy	24,463 +149	+0.6%	+$19.4K	0.73%	35
2021 Q4	$3.71M	Hold	24,314	–	–	0.81%	29
2021 Q3	$3.73M	Buy	+24,314	New	+$4.09M	0.8%	28
2021 Q2	–	Sell	-24,314	Closed	-$3.66M	–	110
2021 Q1	$3.66M	Hold	24,314	–	–	0.91%	23
2020 Q4	$3.68M	Hold	24,314	–	–	1.03%	20
2020 Q3	$3.29M	Hold	24,314	–	–	1.06%	20
2020 Q2	$3.32M	Hold	24,314	–	–	1.17%	19
2020 Q1	$2.62M	Hold	24,314	–	–	1.16%	23
2019 Q4	$2.93M	Hold	24,314	–	–	1.03%	23
2019 Q3	$2.42M	Hold	24,314	–	–	0.87%	31
2019 Q2	$2.65M	Hold	24,314	–	–	0.98%	26
2019 Q1	$2.72M	Hold	24,314	–	–	1%	26
2018 Q4	$2.35M	Hold	24,314	–	–	1.04%	22
2018 Q3	$2.96M	Hold	24,314	–	–	1.17%	19
2018 Q2	$2.67M	Hold	24,314	–	–	1.13%	20
2018 Q1	$2.6M	Sell	24,314 -1,576	-6%	-$175K	1.05%	20
2017 Q4	$2.76M	Buy	25,890 +21,390	+475%	+$2.29M	0.98%	20
2017 Q3	$500K	Hold	4,500	–	–	0.25%	85
2017 Q2	$465K	Buy	+4,500	New	+$443K	0.22%	91

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ferris Capital's IBB Position: Q1 2022 in Review

Ferris Capital increased its iShares Biotechnology ETF (IBB) stake by 0.61% in Q1 2022, buying an estimated $19.4K and bringing the position to 24,463 shares worth $3.19M. The position accounts for 0.73% of the portfolio, ranked #35.

Ferris Capital first reported a position in IBB in Q2 2017 and has held it in 19 quarters since. The position peaked at $3.73M in Q3 2021. 898 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Ferris Capital held 24,463 shares of iShares Biotechnology ETF worth $3.19M as of Q1 2022.
Ferris Capital bought 149 iShares Biotechnology ETF shares in Q1 2022, an estimated $19.4K.
iShares Biotechnology ETF made up 0.73% of Ferris Capital's portfolio in Q1 2022, its #35 holding.
Ferris Capital first reported a position in iShares Biotechnology ETF in Q2 2017 and has held it in 19 quarters since.
Ferris Capital's iShares Biotechnology ETF position peaked at $3.73M in Q3 2021.
898 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.